EZH2 is a biomarker associated with lung cancer diagnosis and immune infiltrates without prognostic specificity: a study based on the cancer genome atlas data

Enhancer of zeste homolog 2 (EZH2) is the catalytic subunit of polycomb repressive complex 2 (PRC2). Dysregulation of EZH2 causes alteration of gene expression and functions, thereby promoting cancer development. Recent studies suggest that EZH2 has a potential prognostic role in patients with non-s...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncology and translational medicine 2023-06, Vol.9 (3), p.99-114
Hauptverfasser:	Wang, Xiaokun, Qi, Min, Zhu, Xu, Zhao, Zhengtong, Cao, Yufeng, Xing, Daijun, Wang, Fuman, Lin, Gaoyang
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!